Jonathan Dawson

Dr. Jonathan Dawson

Centre for Human Development, Stem Cells and Regeneration, Faculty of Medicine, University of Southampton, Southampton SO17 1BJ, UK

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 May 2013 in Advanced Materials
Verified
Journal Article
Closed access
PDF file
JDJonathan Dawson
Jonathan Dawson
RORichard Oreffo
Richard Oreffo

25 July 2017 in Biofabrication
Verified
Journal Article
Open access
TATilman Ahlfeld
Tilman Ahlfeld
GCGianluca Cidonio
Gianluca Cidonio
DKD Kilian
D Kilian
SDS Duin
S Duin
AAA R Akkineni
A R Akkineni
Michael GelinskyMichael Gelinsky
Michael Gelinsky
Three-dimensional printing of cell-laden hydrogels has evolved as a promising approach on the route to patient-specific or complex tissue-engineered constructs. However, it is still challenging to print structures with both, high shape fidelity and cell vitality. Herein, we used a synthetic nanosilicate clay, called Laponite, to build up scaffolds utilising the extrusion-based method 3D plotting. By blending with alginate and methylcellulose, a bioink was developed which allowed easy extrusion, achieving scaffolds with high printing fidelity. Following extrusion, approximately 70%–75% of printed immortalised human mesenchymal stem cells survived and cell viability was maintained over 21 days within the plotted constructs. Mechanical properties of scaffolds comprised of the composite bioink decreased over time when stored under cell culture conditions. Nevertheless, shape of the plotted constructs was preserved even over longer cultivation periods. Laponite is known for its favourable drug delivery properties. Two model proteins, bovine serum albumin and vascular endothelial growth factor were loaded into the bioink. We demonstrate that the release of both growth factors significantly changed to a more sustained profile by inclusion of Laponite in comparison to an alginate-methylcellulose blend in the absence of Laponite. In summary, addition of a synthetic clay, Laponite, improved printability, increased shape fidelity and was beneficial for controlled release of biologically active agents such as growth factors.

10 June 2011 in Advanced Materials
Verified
Journal Article
Closed access
PDF file
JDJonathan Dawson
Jonathan Dawson
JKJanos Kanczler
Janos Kanczler
Xuebin  YangXuebin Yang
Xuebin Yang
GAGeorge S. Attard
George S. Attard
RORichard Oreffo
Richard Oreffo

1 May 2008 in Archives of Biochemistry and Biophysics
Verified
Journal Article
Closed access
JDJonathan Dawson
Jonathan Dawson
RORichard Oreffo
Richard Oreffo

13 March 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
Yang-Hee KimYang-Hee Kim
Yang-Hee Kim
XYXia Yang
Xia Yang
LSLiyang Shi
Liyang Shi
SLStuart A. Lanham
Stuart A. Lanham
JHJons Hilborn
Jons Hilborn
JDJonathan Dawson
Jonathan Dawson
Nanoclays have generated interest in biomaterial design for their ability to enhance the mechanics of polymeric materials and impart biological function. As well as their utility as physical cross-linkers, clays have been explored for sustained localization of biomolecules to promote in vivo tissue regeneration. To date, both biomolecule-clay and polymer-clay nanocomposite strategies have utilised the negatively charged clay particle surface. As such, biomolecule-clay and polymer-clay interactions are set in competition, potentially limiting the functional enhancements achieved. Here, we apply specific bisphosphonate interactions with the positively charged clay particle edge to develop self-assembling hydrogels and functionalized clay nanoparticles with preserved surface exchange capacity. Low concentrations of nanoclay are applied to cross-link hyaluronic acid polymers derivatised with a pendant bisphosphonate to generate hydrogels with enhanced mechanical properties and preserved protein binding able to sustain, for over six weeks in vivo, the localized activity of the clinically licensed growth factor BMP-2.

16 February 2020 in Advanced Functional Materials
Verified
Journal Article
Closed access
PDF file
Babatunde OkesolaBabatunde Okesola
Babatunde Okesola
SNShilei Ni
Shilei Ni
BDBurak Derkuş
Burak Derkuş
CGCarles C. Galeano
Carles C. Galeano
AHAbshar Hasan
Abshar Hasan
Alvaro MataAlvaro Mata
Alvaro Mata